发明授权
- 专利标题： Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
-
申请号： US15659808申请日： 2017-07-26
-
公开(公告)号： US09925189B2公开(公告)日： 2018-03-27
- 发明人: Xin Chen , Peng Cheng , L. Edward Clemens , Jeffrey D. Johnson , Jingyuan Ma , Alison Murphy , Imad Nashashibi , Christopher J. Rabbat , Jiangao Song , Maria E. Wilson , Yan Zhu , Zuchun Zhao
- 申请人： CymaBay Therapeutics, Inc.
- 申请人地址： US CA Newark
- 专利权人： CYMABAY THERAPEUTICS, INC.
- 当前专利权人： CYMABAY THERAPEUTICS, INC.
- 当前专利权人地址： US CA Newark
- 代理机构： Foley & Lardner LLP
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; A61K31/454
摘要：
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.
公开/授权文献
信息查询
IPC分类:
